GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck & Co Inc (XSWX:MRK) » Definitions » E10

Merck (XSWX:MRK) E10 : CHF0.00 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Merck E10?

Note: As E10 is a main component used to calculate Shiller PE Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation sectione below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was CHF0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is CHF0.00 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Merck's average E10 Growth Rate was -1.70% per year. During the past 3 years, the average E10 Growth Rate was 10.60% per year. During the past 5 years, the average E10 Growth Rate was 9.20% per year. During the past 10 years, the average E10 Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Merck was 15.90% per year. The lowest was -6.40% per year. And the median was 2.60% per year.

As of today (2024-05-06), Merck's current stock price is CHF400.00. Merck's E10 for the quarter that ended in Dec. 2023 was CHF0.00. Merck's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Merck was 39.37. The lowest was 17.67. And the median was 26.85.


Merck E10 Historical Data

The historical data trend for Merck's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck E10 Chart

Merck Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.09 2.64 3.17 12.37 -

Merck Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Merck's E10

For the Drug Manufacturers - General subindustry, Merck's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Merck's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Merck's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Merck's Shiller PE Ratio falls into.



Merck E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Merck's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Merck Quarterly Data

per share eps CPI Adj_EPS
201403 0.502 99.695 0.652
201406 0.609 100.560 0.784
201409 0.290 100.428 0.374
201412 2.477 99.070 3.236
201503 0.323 99.621 0.420
201506 0.224 100.684 0.288
201509 0.622 100.392 0.802
201512 0.348 99.792 0.451
201603 0.392 100.470 0.505
201606 0.417 101.688 0.531
201609 0.759 101.861 0.964
201612 0.428 101.863 0.544
201703 0.561 102.862 0.706
201706 0.687 103.349 0.860
201709 -0.019 104.136 -0.024
201712 -0.319 104.011 -0.397
201803 0.256 105.290 0.315
201806 0.624 106.317 0.760
201809 0.707 106.507 0.859
201812 0.684 105.998 0.835
201903 1.121 107.251 1.353
201906 1.018 108.070 1.219
201909 0.733 108.329 0.876
201912 0.904 108.420 1.079
202003 1.209 108.902 1.437
202006 1.123 108.767 1.336
202009 1.061 109.815 1.250
202012 -0.737 109.897 -0.868
202103 1.162 111.754 1.346
202106 0.554 114.631 0.625
202109 1.661 115.734 1.857
202112 1.363 117.630 1.500
202203 1.580 121.301 1.686
202206 1.504 125.017 1.557
202209 1.246 125.227 1.288
202212 1.099 125.222 1.136
202303 0.000 127.348 0.000
202306 0.000 128.729 0.000
202309 0.000 129.860 0.000
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Merck  (XSWX:MRK) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Merck was 39.37. The lowest was 17.67. And the median was 26.85.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Merck E10 Related Terms

Thank you for viewing the detailed overview of Merck's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck (XSWX:MRK) Business Description

Address
126 East Lincoln Avenue, Rahway, NJ, USA, 07065
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.

Merck (XSWX:MRK) Headlines